Journal of Biomedical Engineering and Medical Devices
Open Access

An Overview of Embryonic Stem Cells

Schwartz Ronald^{* *}Correspondence: Schwartz Ronald, Department of Biology, Harvard University, Cambridge, United States, Email:

Author info »

Description

Stem cells are undifferentiated or partially differentiated cells in multicellular animals that can specialize into many types of cells and multiply endlessly to produce additional stem cells. In a cell lineage, they are the earliest form of cells. They can be found in both embryonic and adult organisms, but their functions differ slightly. Progenitor cells, which cannot divide endlessly, and precursor or blast cells, which are normally dedicated to developing into one cell type, are commonly distinguished.

During the blastocyst stage of embryonic development, during days 5–14, around 50–150 cells make up the inner cell mass in mammals. These have the ability to produce stem cells. In the body, they eventually differentiate into all cell kinds (making them pluripotent). The differentiation of the three germ layers– ectoderm, mesoderm, and endoderm begins during the gastrulation stage. When separated and cultivated in vitro, however, they can be maintained in the stem-cell stage and are referred to as embryonic stem cells.

Adult stem cells can be found in a few habitats throughout the body, such as the bone marrow or the gonads. Hematopoietic stem cells, which replace blood and immune cells, basal cells, which maintain the skin epithelium, and mesenchyme stem cells, which maintain bone, cartilage, muscle, and fat cells, are examples of these cells in mammals. Adult stem cells make up a small percentage of the total cell population; they are enormously outnumbered by the progenitor cells and terminally differentiated cells into which they differentiate. Human embryonic stem cells have been cultured and differentiated in stem-cell lines. Isolating these cells has been a contentious procedure because it usually necessitates the destruction of the embryo. In some European countries and Canada, sources for isolating ESCs have been banned, but others, such as the United Kingdom and China, have encouraged the research. Somatic cell nuclear transfer is a cloning technique that can be used to construct a cloned embryo for use in stem cell treatment with its embryonic stem cells. Induced Pluripotent Stem Cells were the name given to these cells (iPSCs).

Embryonic Stem Cells (ESCs)

Embryonic Stem Cells (ESCs) are the cells that make up a blastocyst's inner cell mass before it is implanted in the uterus. The blastocyst stage of human embryonic development occurs 4–5 days after fertilisation and comprises of 50–150 cells. ESCs are pluripotent and give birth to all derivatives of the three germ layers: ectoderm, endoderm, and mesoderm, during development. In other words, given sufficient and necessary stimulation, they can develop into any of the more than 200 cell types found in the adult body. They do not really contribute to the placenta or the extra embryonic membranes.

Identity neural stem cells eventually transform into Radial Glial Progenitor Cells (RGPs). RGPs that are newly generated selfrenew through symmetrical division, forming a pool of progenitor cells. These cells enter a neurogenic stage and begin to divide asymmetrically, resulting in a huge variety of neuron types, each with its own gene expression, morphological, and functional properties. Neurogenesis is the process of producing neurons from radial glial cells. The radial glial cell has a bipolar shape with very elongated processes that span the neural tube wall's thickness. Some glial properties are shared; most notably the production of glial fibrillary acidic protein. The potency of neural stem cells is limited since they are committed to neuronal lineages (neurons, astrocytes, and oligodendrocytes).

Mouse Embryonic Stem cells (mES) or Human Embryonic Stem cells (hES) generated from the early inner cell mass have been used in nearly all studies to date. Both have the core features of stem cells, but they require quite different conditions to remain undifferentiated. Mouse ES cells require the presence of Leukaemia Inhibitory Factor (LIF) in serum media and are cultured on a layer of gelatine as an extracellular matrix.

The expression of many transcription factors and cell surface proteins also helps to characterise a human embryonic stem cell. The glycolipids stage specific embryonic antigen 3 and 4, as well as the keratan sulphate antigens Tra-1-60 and Tra-1-81, are the most often employed cell surface antigens to identify hES cells. Many more proteins are included in the molecular definition of a stem cell, which is still being researched.

Food and Drug Administration approved the first human experiment. Developing use able cells from ES cells while avoiding transplant rejection are just a few of the challenges embryonic stem cell researchers are presently grappling against. If injected directly into another body, pluripotent embryonic stem cells require certain signals for proper differentiation; otherwise, ES cells will differentiate into many different types of cells, resulting in a teratoma. Another factor for the dearth of authorised embryonic stem cell treatments is ethical concerns about the use of unborn human tissue. Human ES cell research and the generation of new human ES cell lines are currently banned or restricted in many countries.